India holds a two to three per cent share of the USD 140-145 billion global CRDMO market but has the potential to become a global leader.

In an international collaboration, researchers have made an important breakthrough in the therapeutic delivery of microRNAs ...

Discovering ultra-conserved elements in the genome and their role in limiting protein production in mice testes.

New research suggests that the formation of stress granules, clumps of proteins and RNA under stress, is a potential root ...

A GROUNDBREAKING cancer vaccine reversed the disease in nine patients, a study has shown. They remained disease free three ...

India’s CRDMO market, currently holding 2-3% of the global share, has the potential to reach $22-25 billion by 2035, says a ...

The Indian Contract Research, Development, and Manufacturing Organization (CRDMO) sector is at an inflection point, with the potential to grow to $22 - $25 billion by 2035, according to a new report, ...

India's CRDMO sector is set to reach USD 22-25 billion by 2035, driven by cost advantages and rapid project startups, according to a BCG and IPSO report. India is emerging as a preferred outsourcing ...

Two researchers from the University of California San Diego have been elected senior members of the National Academy of ...

Our Bureau, Bengaluru Tuesday, February 25, 2025, 15:15 Hrs [IST] ...

This surge is also being driven by India's cost advantages compared to Western countries, 90 per cent faster project startup ...

SHANGHAI, China I5, 2025 I YolTech Therapeutics, a clinical-stage in vivo gene editing company committed to pioneering the next generation of ...